DOSAGE FORMS OF TISSUE KALLIKREIN 1
Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 µg/kg to about 10.0 µg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for trea...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
13.09.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 µg/kg to about 10.0 µg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for treating ischemic and hemorrhagic conditions.
L'invention concerne des formes posologiques d'un ou plusieurs polypeptides de la kallicréine tissulaire 1 (KLK1), qui présentent une dose totale de polypeptides de KLK1 d'environ 0,1 µg/kg à environ 10,0 µg/kg, y compris les formes posologiques sous-cutanées et intraveineuses. L'invention concerne également des dispositifs associés et leurs procédés d'utilisation, par exemple pour le traitement de pathologies ischémiques et hémorragiques. |
|---|---|
| AbstractList | Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 µg/kg to about 10.0 µg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for treating ischemic and hemorrhagic conditions.
L'invention concerne des formes posologiques d'un ou plusieurs polypeptides de la kallicréine tissulaire 1 (KLK1), qui présentent une dose totale de polypeptides de KLK1 d'environ 0,1 µg/kg à environ 10,0 µg/kg, y compris les formes posologiques sous-cutanées et intraveineuses. L'invention concerne également des dispositifs associés et leurs procédés d'utilisation, par exemple pour le traitement de pathologies ischémiques et hémorragiques. |
| Author | VERDOORN, TODD PAULS, RICK |
| Author_xml | – fullname: VERDOORN, TODD – fullname: PAULS, RICK |
| BookMark | eNrjYmDJy89L5WRQdvEPdnR3VXDzD_INVvB3UwjxDA4OdVXwdvTx8fQOcvX0UzDkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GBqYmlmZGjobGRCgBANaXI6s |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | FORMES POSOLOGIQUES DE KALLICREINE TISSULAIRE 1 |
| ExternalDocumentID | CA3054962A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA3054962A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 02 08:59:42 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA3054962A13 |
| Notes | Application Number: CA20183054962 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180913&DB=EPODOC&CC=CA&NR=3054962A1 |
| ParticipantIDs | epo_espacenet_CA3054962A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20180913 |
| PublicationDateYYYYMMDD | 2018-09-13 |
| PublicationDate_xml | – month: 09 year: 2018 text: 20180913 day: 13 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | DIAMEDICA INC |
| RelatedCompanies_xml | – name: DIAMEDICA INC |
| Score | 3.160171 |
| Snippet | Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 µg/kg to about 10.0... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | DOSAGE FORMS OF TISSUE KALLIKREIN 1 |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180913&DB=EPODOC&locale=&CC=CA&NR=3054962A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8IqD0VjT9NIciXdqyOdqOtZPdRlsz2GUO17F_35fQTS96CSGBlw_y8t4v7yMAj-yZuaw0hU4rVN9QI6B6IRiiFEsYJTNcVqko_jhx-hPrbWpPW7DYxcKoPKFblRwROapCfq_Vfb36ecQKlG_l-qlcYNPna5R7gdagY5mMippa0PPCURqkXOPc476WjD081hZzDB-B0gFq0a70_grfezIoZfVbokSncDhCYsv6DFpi2YFjvvt4rQNHcWPvxmrDeutzeAhSaf0hiNrijKQRyQdZNgnJ0Ec4PhyHg4TQCyBRmPO-jqPN9iubcX8_L_MS2gj4xRWQin04UlNz7LltOaIorTnFOhbiRVSF0YXun2Su_-m7gRO5RdLbgZq30K6_NuIORWpd3qvN-AZPaHW6 |
| link.rule.ids | 230,309,783,888,25578,76884 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKc6bTsX5GVB6K9rPLYciXdrS2rUdaye7lbXLYJc5XMV_35fSTS96CSGBfDzykt8vee8F4JE-0z4tNC4rJcI3RASKPOcUWYrO1YKqfVrWXvxRbPpT_XVmzFqw2vnC1HFCv-rgiKhRJep7Ve_Xm59LLKe2rdw-FSssen_xMsuRGnYsglEpmuQMLXecOAmTGLOYLcUTC5e1Tk3VRqJ0gAh7IMLsu29D4ZSy-X2ieCdwOMbG1tUptPi6Cx22-3itC0dR896N2Ub1tmfw4CTi9Ycga4tSkngkC9J06pLQRjoeTtwgJso5EM_NmC9jb_l-Zjmz9-PSLqCNhJ9fAinpwhRIzTSWhm7yeaEvFcxjwge8nKs96P3ZzNU_dffQ8bNolI-COLyGYyEuYfmgaDfQrj4--S0er1VxVwvmG_uveKo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOSAGE+FORMS+OF+TISSUE+KALLIKREIN+1&rft.inventor=VERDOORN%2C+TODD&rft.inventor=PAULS%2C+RICK&rft.date=2018-09-13&rft.externalDBID=A1&rft.externalDocID=CA3054962A1 |